
Request Appointment
353 East 68th StreetNew York, NY 10065
Overview of Dr. Carlo
Dr. Maria Carlo is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Harvard Medical School and has been in practice 8 years. She is one of 508 doctors at Memorial Sloan Kettering Cancer Center and one of 87 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She also speaks multiple languages, including Spanish. She has more than 90 publications and over 500 citings.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2015
- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2012
- Harvard Medical SchoolClass of 2009
Certifications & Licensure
- FL State Medical License 2021 - Present
- NJ State Medical License 2020 - 2027
- CT State Medical License 2023 - 2026
- NY State Medical License 2012 - 2026
- MA State Medical License 2009 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell Carcinoma.Lina Posada Calderon, Mark T Dawidek, Cerise Tang, Minsoo Kim, Grace Zong
European Urology. 2025-09-08 - Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank.Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, Dena Battle, Stephanie A Berg
Urologic Oncology. 2025-08-16 - Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?Tiffany Y Sia, Sara Moufarrij, Juliet Milani, Sarah Kane, Qin Zhou
Gynecologic Oncology. 2025-08-13
Press Mentions
- Research at the Intersection of Oncology & GeneticsDecember 11th, 2019
- Many Actionable Mutations May Be Missed in Current Testing of Advanced RCCJuly 9th, 2018
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: